Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway

Jinbiao Xiong(Tianjin Medical University General Hospital), Qiang Huang(Ministry of Education of the People's Republic of China), Yiyao Cao(Shenzhen Second People's Hospital), Zengguang Wang(Tianjin Medical University General Hospital), Lianmei Guo(Tianjin Medical University General Hospital), Jun Dong(TEDA International Cardiovascular Hospital), Xuejun Yang(Dali University), Nan Yang(Shanghai Cancer Institute), Ruilong Li(Guangxi University), Weidong Yang(Nanjing University), Xun Jin(Tianjin Medical University Cancer Institute and Hospital), Gaochao Guo(Zhengzhou University), Zhijuan Chen(Shandong University)
ACS Omega
February 5, 2021
Cited by 14


Related Papers